A comprehensive retrospective cohort study utilizing a nationwide electronic health records database of over 1.6 million diabetic patients revealed that GLP-1RAs were associated with significantly reduced risks for 10 out of 13 organ-associated cancers, when compared to insulin. This evidence concerns the gene INS and cancer.